Insulin and Oral Hypoglycaemic Agents. I. Physiological and Clinical Pharmacological Aspects
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Drug-induced cardiovascular diseases.
Deglin S, Deglin J, Chung E Drugs. 1977; 14(1):29-40.
PMID: 18329 DOI: 10.2165/00003495-197714010-00002.
References
1.
Mehnert H
. [Pharmacokinetics of blood glucose lowering biguanide derivatives]. Acta Diabetol Lat. 1969; 6 Suppl 1:137-42.
View
2.
Ungar G, PSYCHOYOS S, Hall H
. Action of phenethylbiguanide, a hypoglycemic agent, on tricarboxylic acid cycle. Metabolism. 1960; 9:36-51.
View
3.
Lundbaek K, Nielsen K
. A comparative study of the action of three hypoglycemic compounds on the blood sugar and the islet cells of the pancreas in the rat. Acta Endocrinol (Copenh). 1958; 27(3):325-38.
DOI: 10.1530/acta.0.0270325.
View
4.
Feldman J, Lebovitz H
. Appraisal of the extrapancreatic actions of sulfonylureas. Arch Intern Med. 1969; 123(3):314-22.
View
5.
FRAWLEY T, Shelley T, RUNYAN Jr J, MARGULIES E, CINCOTTI J
. Further studies on the significant role of the liver in sulfonylurea hypoglycemia. Ann N Y Acad Sci. 1959; 82:460-78.
DOI: 10.1111/j.1749-6632.1959.tb44926.x.
View